Company profile
Ocular Therapeutix, Inc Insider Trading
OCULEvery SEC Form 4 insider trading filing for Ocular Therapeutix, Inc (OCUL) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001393434
- Filings
- 116
- Insiders
- 22
- Last filing
- 2026-06-16
Activity summary
No insider transactions in the last 30 days. The most recent was on June 16, 2026, when Dugel Pravin sold 50,092 shares. 116 filings from 22 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Ocular Therapeutix, Inc insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $7.3M.
90 day insight
Over the last 90 days, Ocular Therapeutix, Inc insiders bought $0 across 14 transactions with no open-market sales.
- Most active insider: Dugel Pravin with 4 transactions totaling $0.
- Largest single sale: $123K by Waheed Nadia on Jun 3, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Dugel Pravin | OCUL | Gift | 50,092 | — | — |
| Jun 16, 2026 | Dugel Pravin | OCUL | Gift | 50,092 | — | — |
| Jun 10, 2026 | Warden Charles M | OCUL | Award | 44,000 | — | — |
| Jun 10, 2026 | Robins Jason Shand | OCUL | Award | 15,441 | — | — |
| Jun 10, 2026 | Raines Merilee | OCUL | Award | 14,000 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=OCUL" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Ocular Therapeutix, Inc as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →